Experts question automatic osteoporosis drug holidays

A new editorial urges physicians to individualize treatment decisions based on their patients' fracture risk, rather than automatically interrupting or stopping bisphosphonate therapy after five or three years.

from Today's Healthcare News -- ScienceDaily http://ift.tt/1RoBGD3